Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 2

Starting soon · Not applicable

Conditions studied: Mild Cognitive Impairment

In brief

The goal of this Stage 1 (NIH Stage Model) Intervention Development cross-site project is to develop, using a user-centered design approach, and evaluate an innovative intelligent adaptive software package aimed at providing cognitive and social support and engagement to older adults with mild cognitive impairment (MCI). The system will be designed to adapt to the needs and abilities of the user. The investigator's goal is to develop a unique and highly innovative technology tool that can provide adaptive support to aging individuals with MCI, even as cognition might deteriorate further. Speech data collected as part of an embedded reminiscence feature will advance fundamental knowledge of how speech and language production data might serve as an early indicator of cognitive decline.

Key facts

Study ID

NCT07485712

Run by

Weill Medical College of Cornell University

People needed

290

Starts

2026-08-31

Expected to finish

2027-05-31

Last updated by the study team

2026-05-15

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 62+ years of age
• Able to read English at the 6th grade level
• Have 20/60 vision with or without correction.
• Clinical diagnosis of mild cognitive impairment (MCI)
• Subjective cognitive complaints
• Evidence by clinical evaluation
• Clinical Dementia Rating Global scale of 0.5-2.0
• Probable MCI
• Montreal Cognitive Assessment (MoCA) score of 18-26
• No major Instrumental activities of daily living (IADL) impairments
• Geriatric Depression Scale of 4 or Below
• No diagnosis of dementia

You may not qualify if…

• Blind or have visual impairments that limit their ability to view the technology.
• Deaf or have hearing impairments that limit their ability to answer telephone queries.
• Have a life-limiting/terminal illness
• Severe motor impairment (e.g., severe tremors or debilitating arthritis in their hands) that impairs ability to speak or use dominant hand
• Cognitive impairment (MOCA ≤ 25)

Where it is running

• Florida State University — Tallahassee, Florida, United States
• University of Illinois Urbana-Champaign — Champaign, Illinois, United States
• Weill Cornell Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.